173 related articles for article (PubMed ID: 7573250)
1. Chronic fungal vaginitis: the value of cultures.
Nyirjesy P; Seeney SM; Grody MH; Jordan CA; Buckley HR
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):820-3. PubMed ID: 7573250
[TBL] [Abstract][Full Text] [Related]
2. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
[TBL] [Abstract][Full Text] [Related]
3. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
4. Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center.
Powell AM; Gracely E; Nyirjesy P
J Low Genit Tract Dis; 2016 Jan; 20(1):85-9. PubMed ID: 26083330
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
6. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
7. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
Buscemi L; Arechavala A; Negroni R
Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
[TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
9. High rate of vaginal infections caused by non-C. albicans Candida species among asymptomatic women.
Dan M; Poch F; Levin D
Med Mycol; 2002 Aug; 40(4):383-6. PubMed ID: 12230217
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.
Lynch ME; Sobel JD
J Med Vet Mycol; 1994; 32(4):267-74. PubMed ID: 7983571
[TBL] [Abstract][Full Text] [Related]
11. [Identification of Candida species causing vaginitis in Mexican patients].
Rivera-Sánchez R; Flores-Paz R; Arriaga-Alba M
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):634-6. PubMed ID: 17194389
[TBL] [Abstract][Full Text] [Related]
12. Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
Novikova N; Rodrigues A; Mårdh PA
Infect Dis Obstet Gynecol; 2002; 10(2):89-92. PubMed ID: 12530485
[TBL] [Abstract][Full Text] [Related]
13. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
14. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
15. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
Sobel JD; Sobel R
Expert Opin Pharmacother; 2018 Jun; 19(9):971-977. PubMed ID: 29932786
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole-resistant Candida albicans vulvovaginitis.
Marchaim D; Lemanek L; Bheemreddy S; Kaye KS; Sobel JD
Obstet Gynecol; 2012 Dec; 120(6):1407-14. PubMed ID: 23168767
[TBL] [Abstract][Full Text] [Related]
17. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
Iavazzo C; Gkegkes ID; Zarkada IM; Falagas ME
J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
[TBL] [Abstract][Full Text] [Related]
19. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
20. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Fan SR; Liu XP
Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
